Abstract
In order to understand the mechanism for neoplastic cell invasion, we utilized binding studies of TIMP-2, gelatinase A and the TIMP-2/gelatinase A complex to neoplastic cells and correlated these results with their capacity to invade a matrix substrate in a modified Boyden chamber assay. Binding studies were performed on malignant human breast cancer cells and fibrosarcoma cells with rTIMP-2, rGelatinase A, and TIMP-2/gelatinase Acomplex. Competition studies of the binding characteristics of these proteins indicated that gelatinase A and gelatinase A/TIMP-2 complex bound to the surface of cells via TIMP-2. Furthermore, the localization of either latent or active protease to the surface of MDA-MB-435 breast cancer cells facilitated the invasion of these neoplastic cells through a matrigel barrier. This suggests that in addition to binding this complex, these cells can activate this pro-enzyme-inhibitor complex and use this activity to facilitate cellular invasion. Moreover, their enhanced invasion was suppressed by exogenous additions of rTIMP-2. A working hypothesis and model for the role of gelatinase A/TIMP-2 complex in cellular invasion is presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albini, A., Melchiori, A., Santi, L., Liotta, L. A., Brown, P. D. and Stetler-Stevenson, W. G., 1991, Tumor cell invasion inhibited by TIMP-2 [see comments], J. Natl. Cancer Inst. 83: 775–9.
Barsky, S. J., Rao, C. N., Williams, J. E. and Liotta, L. A., 1984, Laminin molecular domains which alter metastsis in a murine model, J. Clin. Invest. 74: 843–848.
Birkedal-Hansen, H., Moore, W. G. L., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J. A., 1993, Matrix Metalloproteinases: A Review, Crit. Rev. Oral Biol. Med. 4: 197–250.
Brown, P. D., Bloxidge, R. E., Stuart, N. S. A., Gatter, K. C. and Carmichael, J., 1993, Association Between Expression of Activated 72-Kilodalton Gelatinase and Tumor Spread in Non-Small-Cell Lung Carcinoma, J. Natl. Cancer Inst. 85: 574–578.
Brown, P. D., Kleiner, D. E., Unsworth, E. J. and Stetler-Stevenson, W. G., 1993, Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex, Kidney Int. 43: 163–170.
Campo, E., Merino, M. J., Liotta, L., Neumann, R. and Stetler-Stevenson, W., 1992, Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue, Hum Pathol 23: 1395–1401.
DeClerck, Y., Szpirer, C, Aly, M. S., Cassiman, J.-J., Eeckhout, Y. and Rousseau, G., 1992, The Gene for Tissue Inhibitor of Metalloproteinases-2 Is Localized on Human Chromosome Arm 17q25, Genomics 14:782–784.
DeClerck, Y. A., Yean, T.-D., Ratzkin, B. J., Lu, H. S. and Langley, K. E., 1989, Purification and Characterization of Two Related but Distinct Metalloproteinase Inhibitors Secreted by Bovine Aortic Endothelial Cells, J. Biol. Chem. 264: 17445–17453.
DeClerck, Y. A., Yean, T. D., Lee, Y., Tomich, J. M. and Langley, K. E., 1993, Characterization of the Functional Domain of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2), Biochem. J. 289: 65–69.
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G. and Reynolds, J. J., 1985, Sequence of Human Tissue Inhibitor of Metalloproteinases and Its Identity to Erythroid-Potentiating Activity, Nature 318: 66–69.
Emonard, H. P., Remacle, A. G., No:el, A. C., Grimaud, J. A., Stetler-Stevenson, W. G. and Foidart, J. M., 1992, Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res. 52: 5845–8.
Fridman, R., Fuerst, T. R., Bird, R. E., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta. L. A., Bennan, M. L. and Stetler-Stevenson, W. G., 1992, Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions,J. Biol. Chem. 267: 15398–405.
Hewitt, R. E., Leach, I. H., Powe, D. G. Clark, I. M., Cawston, T. E. and Turner, D. R., 1991, Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int. J. Cancer 49: 666–672.
Keskioja, J., Lohi, J., Tuuttila, A., Tryggvason, K. and Vartio, T., 1992, Proteolytic Processing of the 72,000-Da Type-IV Collagenase by Urokinase Plasminogen Activator, Exp. Cell Res/ 202: 471–476.
Kleiner, D., Jr., Tuuttila, A., Tryggvason, K. and Stetler-Stevenson, W. G., 1993, Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2), Biochemistry 32: 1583–92.
Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P. and Edwards, D. R., 1994, Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Is an Extracellular Matrix-associated Protein with a Distinctinve Pattern of Expression in Mouse Cells and Tissues, J. Biol. Chem. 269: 9352–9360.
Liotta, L. A. and Stetler-Stevenson, W. G., 1990, Metalloproteinases and cancer invasion, Cancer Biology 1: 99–106.
Melchiori, A., Albini, A., Ray, J. M. and Stetler-Stevenson, W. G., 1992, Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment, Cancer Res. 52: 2353–6.
Muir, D., 1994, Metalloproteinase-Dependent Neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor, Exp. Cell Res. 210: 243–252.
Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O’Shea, M. and Docherty, A. J., 1991, The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity, Biochemistry 30: 8097–102.
Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. I., Eaton, D. and Docherty, A. J., 1992, The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases, Biochem. J. 283: 637–641.
Nomura, K. and Suzuki, N., 1993, Stereo-specific inhibition of sea urchin envelysin (hatching enzyme) by a synthetic autoinhibitor peptide with a cysteine-switch consensus sequence., FEBS Lett. 321: 84–88.
O’Shea, M., Willenbrock, F., Williamson, R. A., Cockett, M. I., Freedman, R. B., Reynolds, J. J., Docherty, A. J. and Murphy, G., 1992, Site-Directed Mutations That Alter the Inhibitory Activity of the Tissue Inhibitor of Metalloproteinases-1: Importance of the N-Terminal Region Between Cysteine 3 and Cysteine 13, Biochemistry 31: 10146–10152.
Okada, Y., Morodomi, T., Enghild, J. J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G. and Nagase, H., 1990, Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties, Eur. J. Biochem. 194: 721–730.
Park, A. J., Matrisian, L. M., Keils, A. F., Pearson, R., Yuan, Z. Y. and Navre, M., 1991, Mutational Analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the “cysteine switch”, J. Biol. Chem. 266: 1584–1590.
Pavloff, N., Staskus, P. W., Kishnani, N. S. and Hawkes, S. P., 1992, A New Inhibitor of Metalloproteinases from Chicken: ChIMP-3. A Third Member of the TIMP Family, J. Biol. Chem.261: 17321–17326.
Rodbard, D., 1973, Mathematics of Horomonoe-receptor interaction. 1. Basic Principles, Adv. Exp. Med. Biol. 36: 289–326.
Salo, T., Liotta, L. A., Keski-Oja, J., Turpeennieme-Hujanen, T. and Tryggvason, K., 1982, Secretion of a Basement Membrane Collagen Degrading Enzyme and Plasminogen Activator by Transformed Cells-Role in Metastasis, Int. J. Cancer 30: 669–673.
Sanchez-Lopez, R., Alexander, C. M., Behrendtsen, O., Breathnach, R. and Werb, Z., 1993, Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins, J. Biol. Chem. 268: 7238–47.
Sanchez-Lopez, R., Nicholson, R., Gesnel, M.-C, Matrisian, L. M. and Breathnach, R., 1988, Structure-Function Relationships in the Collagenase Gene Family Member Transin, J. Biol. Chem. 263:11892–11899.
Sato, H., Kida, Y, Mai, M., Endo, Y, Sasaki, T., Tanaka, J. and Seiki, M., 1992, Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells, Oncogene 7: 11–S3.
Sato, H., Takahisa, T., Okada, Y, Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M., 1994, A matrix metalloproteinase expressed on the surface of invasive cells, Nature 370: 61–65.
Stetler-Stevenson, W. G., Bersch, N. and Golde, D. W., 1992, Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity, FEBS Lett. 296: 231–4.
Stetler-Stevenson, W. G., Krutzsch, H. C. and Liotta, L. A., 1989, Tissue Inhibitor of Metalloproteinase (TIMP-2), J. Biol. Chem. 264: 17374–17378.
Stetler-Stevenson, W. G., Liotta, L. A. and Seidin, M. F., 1992, Linkage analysis demonstrates that the Timp-2 locus is on mouse chromosome 11, Genomics 14: 828–9.
Stetler-Stevenson, W. G., Talano, J. A., Gallagher, M. E., Krutzsch, H. C. and Liotta, L. A., 1991, Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment, Amer. J. Med. Sci. 302: 163–70.
Strongin, A. Y., Collier, I. E., Krasnov, P. A., Genrich, L. T., Maimer, B. L. and Goldberg, G. L., 1993, Human 92 kDa Type-IV Collagenase - Functional Analysis of Fibronectin and Carboxyl-End Domains, Kidney Int. 43: 158–162.
Van Ward, H. and Birkedal-Hansen, H., 1990, The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family, Proc. Natl. Acad. Sci. USA 87: 5578–5582.
Ward, R. V., Atkinson, S. J., Slocombe, P. M., Docherty, A. J., Reynolds, J. J. and Murphy, G., 1991, Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes, Biochim. Biophys. Acta. 1079: 242–6.
Werb, Z., Mainardi, C. L., Vater, C. and Harris, E. D., 1977, Endogenous Activation Of Latent Collagenase By Rheumatoid Synovial Cells. Evidence for a Role of Plasminogen Activator, New Engl. J. Med. 296: 1017–1023.
Williamson, R., Marston, F., Angal, S., Koklitis, P., Panico, M., Morris, H., Carne, A., Smith, B., Harris, T. and Freedman, R., 1990, Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP), Biochem. J. 268: 267–274.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Corcoran, M.L., Emmert-Buck, M.R., McClanahan, J.L., Pelina-Parker, M., Stetler-Stevenson, W.G. (1996). TIMP-2 Mediates Cell Surface Binding of MMP-2. In: Suzuki, K., Bond, J.S. (eds) Intracellular Protein Catabolism. Advances in Experimental Medicine and Biology, vol 389. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0335-0_36
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0335-0_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8003-0
Online ISBN: 978-1-4613-0335-0
eBook Packages: Springer Book Archive